U.S. Markets closed

Adamas Skyrockets on FDA Approval for Dyskinesia Treatment - Biotech Movers

Armie Margaret Lee

The Emeryville, Calif.-based firm secures FDA approval for Gocovri as a treatment for dyskinesia in Parkinson's disease patients.